Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Antimicrobial Resistance Initiative topic
No spam. Unsubscribe anytime.
CDC reviews 10 years of Antimicrobial Resistance Solutions Initiative
Summary
CDC panelists marked a decade of the Antimicrobial Resistance (AR) Solutions Initiative, saying federal investments expanded genomic surveillance, lab capacity, stewardship and global partnerships that now underpin faster outbreak detection and better patient care.
The Centers for Disease Control and Prevention on a webinar reviewed 10 years of work funded through the Antimicrobial Resistance Solutions Initiative, saying the program built national surveillance systems and supported innovations that improve detection, prevention and clinical care.
Moderator Stephanie McBride, associate director for policy and partnerships in CDC’s Antimicrobial Resistance Coordination and Strategy Unit, said the Initiative grew from the 2014 U.S. national strategy and the 2015 National Action Plan and the first congressional appropriation in fiscal year 2016 that seeded implementation. She said AR Solutions funding has enabled coordination across at least eight CDC divisions to address nearly two dozen drug‑resistant pathogens and to strengthen detection and response infrastructure.
“Over the past 10 years, the AR Solutions Initiative funding to health departments and partners has built a national infrastructure for detection and response, enhanced health care quality and safety, improved the appropriate use of antibiotics and antifungals, strengthened awareness and developed innovative solutions,” McBride said.
Panelists highlighted specific system improvements as tangible results of the initiative. Dr. Gwen Biggerstaff described modernized genomic surveillance platforms (PulseNet, NARMS, FoodNet) and expanded use of whole‑genome sequencing to detect outbreaks earlier. Dr. Mike Bell said investments helped create a workforce in state and local health departments and connect roughly 39,000 facilities through the National Healthcare Safety Network to track health‑care quality. Commander Paige Armstrong described CDC country offices and regional presence in more than 60 countries that have helped build laboratory and surveillance capacity globally. Dr. Cliff McDonald discussed short‑term applied‑research contracts and the new Advancing Microbiome Solutions for Better Health initiative to develop microbiome‑based interventions.
The webinar closed with each panelist saying the next decade should focus on sustaining and integrating data systems, expanding diagnostic capacity and translating microbiome and digital decision‑support research into practical interventions.
Panelists directed listeners to CDC resources and the AR investment map for more detail on program activities and funding.
